ROYAL BANK OF CANADA - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$017
+6.2%
0.00%
Q2 2023$0
-100.0%
16
-99.9%
0.00%
Q1 2023$37,00020,012
+35635.7%
0.00%
Q4 2022$056
+27.3%
0.00%
Q3 2022$0440.0%0.00%
Q2 2022$0440.0%0.00%
Q1 2022$044
+4.8%
0.00%
Q4 2021$0
-100.0%
42
-70.0%
0.00%
Q3 2021$1,000140
+133.3%
0.00%
Q2 2021$0
-100.0%
60
-78.3%
0.00%
Q1 2021$2,000
+100.0%
276
+142.1%
0.00%
Q4 2020$1,000114
+3700.0%
0.00%
Q3 2020$030.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders